Novitium Pharma

The US Food and Drug Administration is starting to post information to key drug databases on its website again after most of its public communications were halted 21 January. The Center for Drug Evalu

Solid Q4 numbers have set ANI Pharmaceuticals, Inc. up for a pivotal 2023, as better-than-expected sales of both generic products and established brands drove up revenue. The firm’s pivotal Cortroph

Because every chemistry, manufacturing and controls review is another adventure, it’s worth looking at some of the bumps in the road and decisions made along the way as assessors in the FDA’s Office o

Operations at ANI Pharmaceuticals ’ manufacturing plant in Oakville, Ontario, are expected to cease by Q1 2023 as part of ongoing initiatives to “capture operational synergies” following the company’